Growth Hormone

PEG-MGF

PEGylated Mechano Growth Factor

Long-acting version of the muscle satellite cell activator

PEG-MGF is a pegylated version of Mechano Growth Factor with an extended half-life from minutes to hours. The PEG chain provides systemic distribution rather than localised action.

PEG
💉

Admin routes

Subcutaneous, Intramuscular

🔬

Popularity

Niche

Side effects

Generally mild

🏪

AU vendors

0 rated

Key benefits

1Extended half-life compared to native MGF (hours vs minutes)
2Can be administered subcutaneously for systemic effects
3Activates satellite cells throughout the body rather than locally

📈What to expect

1
Week 1-2

Improved recovery between training sessions

2
Week 4-6

Gradual improvements in lean mass and muscle fullness

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Systemic muscle recovery (community protocol)

Dose

200-400 mcg

Frequency

Once daily or every other day (subcutaneous)

Duration

4-6 week cycles

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Research status|Preclinical - no human trials

Overview

PEG-MGF was developed to address the extremely short half-life of native MGF. By attaching a polyethylene glycol (PEG) chain, the peptide resists enzymatic degradation and circulates for hours instead of minutes. This allows subcutaneous injection rather than requiring direct intramuscular injection into target muscles. The trade-off is that PEG-MGF loses the localised, site-specific action of native MGF and instead works systemically. It remains a research compound with no human clinical trials.

⚙️How it works

Same as native MGF: activates muscle satellite cells through a receptor distinct from IGF-1R, promoting proliferation and fusion with existing muscle fibres. The PEG chain prevents enzymatic degradation, extending the half-life from minutes to approximately 6-8 hours, allowing systemic distribution through subcutaneous injection.

Side effects

Injection site reactions
mildCommon
Lethargy in some users
mildUncommon

📅Research history

2005

PEGylated MGF variants developed to extend half-life

References

  1. [1]Goldspink G. 'Mechanical signals, IGF-I gene splicing, and muscle adaptation.' Physiology, 2005.

Frequently asked questions

Related peptides

Community experiences

Share your experience with PEG-MGF. Effects, side effects, protocol details - help others make informed decisions.

Write a review

Rating:

No community reviews yet. Be the first to share your experience with PEG-MGF.

Need to calculate your dose?

Use our free reconstitution calculator to work out syringe units for PEG-MGF.

Open Calculator

Found this useful?

Share this guide

Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.